2020 ASCO Virtual Direct™ Highlights

 

GI
07:15

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on Rectal & Esophageal Cancer: What Are the OPRA, ECOG-ACRIN, and NRG/RTOG 1010 Trial Results? What Is the Efficacy of Trastuzumab/Trimodality Therapy for Esophageal Cancer?

FEATURING Kristina Mirabeau-Beale
  • 24 views
  • February 12, 2021
36:52

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on CRC: Pembro vs. Chemo for MSI-H/dMMR Metastatic Colorectal Cancer - Are There Improvements in PFS and ORR?

FEATURING Christina Gomez
  • 25 views
  • September 16, 2020
08:49

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on mCRC: FDA Approved Encorafenib + Cetuximab Combination w/ or w/o Binimetinib for BRAF V600E mCRC - Which Option Has Better Overall Efficacy? Is This the New SoC?

FEATURING Christina Gomez
  • 81 views
  • September 16, 2020
07:19

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on HER2-Expressing mCRC: Was There Any Activity in HER2+ Patients Treated With T-DXd ADC?

FEATURING Christina Gomez
  • 126 views
  • September 16, 2020
  • 1
07:11

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Stage 3 Rectal Cancer: Can We Reduce Distant Metastases Without Increasing Local Failure? Are There Changes to Overall QoL With Short-Course RT Followed by Chemo Before TME?

FEATURING Christina Gomez
  • 308 views
  • September 16, 2020
19:57

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on GE Adenocarcinomas: How Does Neoadjuvant Trastuzumab Affect Treatment? Are there Improvements From the Addition of Tras+Pertuzumab?

FEATURING Daniel Catenacci
  • 175 views
  • September 16, 2020
  • 1
09:58

2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclitaxel + Ramucirumab, T-DXd in HER2+Disease

FEATURING Daniel Catenacci
  • 386 views
  • September 16, 2020
05:59

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Pancreatic Cancer: Perioperative Chemo + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel for PDAC - Which Option Improves Chemo Delivery and Early Control of Systemic Disease?

FEATURING Daniel Catenacci
  • 507 views
  • September 16, 2020
  • 1